New Therapeutic Targets in Rheumatoid Arthritis
Buch in deiner Nähe kaufen
Beschreibung
The volume focuses on therapeutic targets that were identified after TNF blockade and that have recently been registered or are currently under development for the treatment of rheumatoid arthritis. Each chapter discusses the biological rationale in great detail, including in vitro work and work in animal models, and where appropriate, results from clinical trials.
The book is written by an international authorship of experts in this field. It is of interest to rheumatologists, immunologists, internists, investigators in immunology and rheumatology as well as the pharmaceutical industry.
The volume focuses on therapeutic targets that were identified after TNF blockade and that have recently been registered or are currently under development for the treatment of rheumatoid arthritis. Each chapter discusses the biological rationale in great detail, including in vitro work and work in animal models, and where appropriate, results form clinical trials. The book is written by an international authorship of experts in this field. It is of interest to rheumatologists, immunologists, internists, the pharmaceutical industry, and to investigators in immunology and rheumatology.
Focuses on therapeutic targets that have recently been registered or are currently under development. Each chapter discusses the biological rationale in great detail including results from clinical trials. Written by an international authorship of experts in this field.
Autor*in
Paul-Peter Tak
Themen in »New Therapeutic Targets in Rheumatoid Arthritis«
Arthritis Chemokine Drug Target Interleukine antibody cell clinical trial diseases drug immunobiology immunology inflammation research rheumatoid arthritis